Regulation, Compliance & Legal › Sub-category
Licence / Approval / Cancellation
14 articles
Regulatory approvals and licensing activities are shaping developments across various sectors. Aditya Birla Capital secured an RBI factoring license, while Healthy Life Agritec received a nine-year manufacturing license from the Karnataka State Pollution Control Board, enabling continued production of sauces. Meanwhile, Lupin received tentative FDA approval for a generic COPD treatment, expanding its respiratory portfolio and positioning it to compete in a market with substantial annual sales. These approvals, alongside actions like the RBI's restrictions on Nagar Sahakari Bank and cancellations of NBFC registrations, highlight the evolving regulatory landscape and its potential impact on financial institutions and businesses seeking operational expansion.
IDBI Bank Incorporates IDBI Foundation Subsidiary
IDBI Bank incorporated IDBI Foundation as a wholly owned Section 8 subsidiary on May 19, 2026.
The subsidiary will implement the Bank's CSR initiatives focusing on education, healthcare, and rural dev
Dhoot Industrial Finance FY26 Results, Dividend, NBFC Exit
Board approved audited FY26 results with net profit of ₹1,798.91 lakhs and recommended a final dividend of ₹1.50 per share.
Company plans to apply for RBI deregistration as an NBFC, surrendering its c
ZikZuk Gets RBI Prepaid Payment Issuer Authorisation
ZikZuk Technologies Ltd received RBI authorisation to operate as a Prepaid Instrument (PPI) Issuer under the 2007 Settlement Systems Act.
The PPI licence lets ZikZuk launch digital wallets, prepaid ca
Bharat Parenterals FY26 Transition Year, Innoxel Inflection
Bharat Parenterals reported FY26 as a transition year with consolidated revenue of ₹345.4 crore, flat YoY, but EBITDA surged 485% to ₹15.8 crore.
Subsidiary Innoxel Lifesciences grew 174% to ₹72.4 cro
Shaily Engineering Plastics Launches Semaglutide Pen Injector
Shaily Engineering Plastics announces regulatory approvals for its ShailyPen Neo™ device incorporated in generic Semaglutide injection.
The spring-driven pen injector platform received USFDA tentative
Sambhv Steel Receives CTE for Stainless Steel Mill
Sambhv Steel Tubes received Consent to Establish from Chhattisgarh Environment Conservation Board for new Cold Rolling Mill.
The facility at Kuthrel Unit-II will have production capacity of 1,18,000 m
Sambhv Steel Receives CTO for Doubled Cold Rolling Capacity
Sambhv Steel Tubes received regulatory approval to double Cold Rolling Mill capacity from 58,000 to 116,000 MTPA.
The Consent to Operate amendment was granted by Chhattisgarh Environment Conservation
Aditya Birla Capital Receives RBI Factoring License
Aditya Birla Capital Ltd received RBI registration certificate to operate factoring business on 19 May 2026.
The disclosure is made under SEBI Listing Regulations Regulation 30 requirements.
The compa
Black Rose Industries Gets Permanent GPCB Closure Revocation
Gujarat Pollution Control Board permanently revoked closure directions for the company's Jhagadia plant.
The revocation was issued under Section 33-A of the Water Pollution Act, 1974 via letter dated
Healthy Life Agritec Receives 9.5-Year Manufacturing Licenses
Healthy Life Agritec Limited received Consent to Operate licenses from the Karnataka State Pollution Control Board for its Bangalore manufacturing unit.
The licenses are valid for over nine years, fro
Lupin Receives Tentative FDA Approval for Revefenacin
Lupin received tentative FDA approval for generic Revefenacin Inhalation Solution, 175 mcg/3 mL unit-dose vials.
The product is bioequivalent to Mylan's Yupelri® for COPD maintenance treatment with $2
RBI Caps Nagar Sahakari Lending, ₹10k Withdrawals
RBI issued directions restricting Nagar Sahakari Bank from granting new loans, making investments, borrowing, or accepting fresh deposits without prior approval.
Bank may allow withdrawals up to ₹10,0
KP Energy Q4 FY26 Revenue Jumps 55% YoY
KP Energy reported record annual revenue of ₹1,505.54 crore for FY26, a 57% YoY growth, with Q4 revenue reaching ₹633.93 crore.
The company's order book stands at 2 GW valued at ₹3,000 crore, with 50%
FDC Limited Receives US FDA ANDA Approval for Cefixime
FDC Limited received US FDA approval for its Abbreviated New Drug Application for Cefixime for Oral Suspension.
The approval covers two dosage strengths: 100 mg/5 mL and 200 mg/5 mL formulations.
This